X4 Pharmaceuticals, Inc Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
X4 Pharmaceuticals, Inc quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • X4 Pharmaceuticals, Inc Operating Lease, Payments for the quarter ending September 30, 2024 was $345K, unchanged year-over-year.
  • X4 Pharmaceuticals, Inc Operating Lease, Payments for the twelve months ending September 30, 2024 was $1.38M, a 0.36% increase year-over-year.
  • X4 Pharmaceuticals, Inc annual Operating Lease, Payments for 2023 was $1.39M, a 2.29% increase from 2022.
  • X4 Pharmaceuticals, Inc annual Operating Lease, Payments for 2022 was $1.35M, a 7.72% increase from 2021.
  • X4 Pharmaceuticals, Inc annual Operating Lease, Payments for 2021 was $1.26M, a 67.1% decline from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.39M +$31K +2.29% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 $1.35M +$97K +7.72% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $1.26M -$2.56M -67.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-21
2020 $3.82M +$2.81M +279% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-21
2019 $1.01M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.